Lorraine Spector

Array ( [id] => 1306279 [patent_doc_number] => 06617160 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-09 [patent_title] => 'Anti-human VEGF receptor Flt-1 monoclonal antibody' [patent_app_type] => B1 [patent_app_number] => 09/119014 [patent_app_country] => US [patent_app_date] => 1998-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 14 [patent_no_of_words] => 20450 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/617/06617160.pdf [firstpage_image] =>[orig_patent_app_number] => 09119014 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4403427 [patent_doc_number] => 06270993 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-07 [patent_title] => 'VEGF-binding polypeptide' [patent_app_type] => 1 [patent_app_number] => 9/051363 [patent_app_country] => US [patent_app_date] => 1998-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 23 [patent_no_of_words] => 18111 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/270/06270993.pdf [firstpage_image] =>[orig_patent_app_number] => 051363 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4433880 [patent_doc_number] => 07897732 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-01 [patent_title] => 'Antibodies to heparin-binding growth factor (HBGF) polypeptides' [patent_app_type] => utility [patent_app_number] => 09/113924 [patent_app_country] => US [patent_app_date] => 1998-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11091 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/897/07897732.pdf [firstpage_image] =>[orig_patent_app_number] => 09113924 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4355955 [patent_doc_number] => 06291661 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-18 [patent_title] => 'flt3-L mutants and method of use' [patent_app_type] => 1 [patent_app_number] => 9/109100 [patent_app_country] => US [patent_app_date] => 1998-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 26982 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/291/06291661.pdf [firstpage_image] =>[orig_patent_app_number] => 109100 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4256572 [patent_doc_number] => 06204011 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-20 [patent_title] => 'Human receptor tyrosine kinase, KDR' [patent_app_type] => 1 [patent_app_number] => 9/098707 [patent_app_country] => US [patent_app_date] => 1998-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 12820 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/204/06204011.pdf [firstpage_image] =>[orig_patent_app_number] => 098707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4177544 [patent_doc_number] => 06149916 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-21 [patent_title] => 'Methods of accelerating wound healing or of stimulating connective tissue cell growth using connective tissue growth factor' [patent_app_type] => 1 [patent_app_number] => 9/097179 [patent_app_country] => US [patent_app_date] => 1998-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9125 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/149/06149916.pdf [firstpage_image] =>[orig_patent_app_number] => 097179 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4180678 [patent_doc_number] => 06150120 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-21 [patent_title] => 'Methods to assay a thrombopoietin signaling defect in polycythemia vera platelets' [patent_app_type] => 1 [patent_app_number] => 9/081618 [patent_app_country] => US [patent_app_date] => 1998-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 16 [patent_no_of_words] => 6896 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/150/06150120.pdf [firstpage_image] =>[orig_patent_app_number] => 081618 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4355908 [patent_doc_number] => 06190884 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-20 [patent_title] => 'Connective tissue growth factor' [patent_app_type] => 1 [patent_app_number] => 9/080715 [patent_app_country] => US [patent_app_date] => 1998-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7682 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/190/06190884.pdf [firstpage_image] =>[orig_patent_app_number] => 080715 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4239443 [patent_doc_number] => 06143869 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-07 [patent_title] => 'CD30 ligand oligomers and polypeptides' [patent_app_type] => 1 [patent_app_number] => 9/079785 [patent_app_country] => US [patent_app_date] => 1998-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28678 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/143/06143869.pdf [firstpage_image] =>[orig_patent_app_number] => 079785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4070129 [patent_doc_number] => 06069006 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-30 [patent_title] => 'Connective tissue growth factor (CTGF) regulatory nucleic acid sequences' [patent_app_type] => 1 [patent_app_number] => 9/054368 [patent_app_country] => US [patent_app_date] => 1998-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 18 [patent_no_of_words] => 20572 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/069/06069006.pdf [firstpage_image] =>[orig_patent_app_number] => 054368 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4180397 [patent_doc_number] => 06150101 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-21 [patent_title] => 'Methods of identifying a composition that alters connective tissue growth factor expression' [patent_app_type] => 1 [patent_app_number] => 9/054274 [patent_app_country] => US [patent_app_date] => 1998-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 16 [patent_no_of_words] => 20540 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/150/06150101.pdf [firstpage_image] =>[orig_patent_app_number] => 054274 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4403857 [patent_doc_number] => 06232064 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-15 [patent_title] => 'Methods of diagnosing a pathology characterized by a cell proliferative disorder associated with connective tissue growth factor' [patent_app_type] => 1 [patent_app_number] => 9/056704 [patent_app_country] => US [patent_app_date] => 1998-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 26 [patent_no_of_words] => 18472 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/232/06232064.pdf [firstpage_image] =>[orig_patent_app_number] => 056704 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6655889 [patent_doc_number] => 20030077663 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-24 [patent_title] => 'METHOD FOR DETERMINING CYTOKINE RECEPTOR ACTIVATION BY THE USE OF AN ANTIBODY' [patent_app_type] => new [patent_app_number] => 09/044154 [patent_app_country] => US [patent_app_date] => 1998-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7119 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20030077663.pdf [firstpage_image] =>[orig_patent_app_number] => 09044154 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6655889 [patent_doc_number] => 20030077663 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-24 [patent_title] => 'METHOD FOR DETERMINING CYTOKINE RECEPTOR ACTIVATION BY THE USE OF AN ANTIBODY' [patent_app_type] => new [patent_app_number] => 09/044154 [patent_app_country] => US [patent_app_date] => 1998-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7119 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20030077663.pdf [firstpage_image] =>[orig_patent_app_number] => 09044154 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6655889 [patent_doc_number] => 20030077663 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-24 [patent_title] => 'METHOD FOR DETERMINING CYTOKINE RECEPTOR ACTIVATION BY THE USE OF AN ANTIBODY' [patent_app_type] => new [patent_app_number] => 09/044154 [patent_app_country] => US [patent_app_date] => 1998-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7119 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20030077663.pdf [firstpage_image] =>[orig_patent_app_number] => 09044154 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6655889 [patent_doc_number] => 20030077663 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-24 [patent_title] => 'METHOD FOR DETERMINING CYTOKINE RECEPTOR ACTIVATION BY THE USE OF AN ANTIBODY' [patent_app_type] => new [patent_app_number] => 09/044154 [patent_app_country] => US [patent_app_date] => 1998-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7119 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20030077663.pdf [firstpage_image] =>[orig_patent_app_number] => 09044154 [rel_patent_id] =>[rel_patent_doc_number] =>)